Publication: Targeted Oncology, National
Daniel Hamstra, MD, PhD, radiation oncologist, Texas Center for Proton Therapy, Texas Oncology, discusses radiotherapy in different doses as a treatment for prostate cancer. Hamstra says that shorter regimens of radiotherapy for men whose prostates remained intact post-surgery proved to be noninferior when compared to longer regimens. He adds that these shorter regimens are more convenient for patients and more cost effective.
Read the full story at Targeted Oncology, National.